Astellas Pharma Inc.
$9.65
24H
Market Cap
Volume
Supply
Price Chart
About Astellas Pharma Inc. - ALPMF
Astellas Pharma is a Japanese multinational pharmaceutical company that develops and markets drugs for various therapeutic areas, including urology, immunology, and oncology. It was formed from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. in April 2005.
What are Astellas Pharma Inc.'s core values and mission statement?
Astellas Pharma's core values revolve around being patient-focused, conducting business with integrity, showing respect for individuals, and aiming to produce better results through teamwork. Their mission is to improve the health of people around the world through innovative and reliable pharmaceutical products.
Who founded Astellas Pharma Inc. and when?
ASTELLAS PHARMA was founded through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. on April 1, 2005.
Who leads Astellas Pharma Inc.?
The leadership of Astellas Pharma is typically headed by a Chief Executive Officer (CEO), but the specific individual holding this position may change over time, reflecting internal promotions, retirements, or new appointments.
Where is Astellas Pharma Inc. located, and what is its base country?
Astellas Pharma has its headquarters in Tokyo, Japan.
On which exchanges is Astellas Pharma Inc. traded?
Astellas Pharma Inc. is primarily listed and traded on the Tokyo Stock Exchange in Japan.
Historical data
Astellas Pharma Inc. (ALPMF) Price Live Data
The live price of Astellas Pharma Inc. (ALPMF) is $9.65, with a trading volume of 22,700 in the last 24 hours. Wrapstocks updates the ALPMF price in real-time. Astellas Pharma Inc. is up 1.58% in the last 24 hours. The company has a live market cap of $17,302,351,872.00 and a supply of 1,792,989,831 ALPMF stocks.
Astellas Pharma Inc. (ALPMF) is traded on OTC Markets U.S., and currently, the market is closed; trading will be resumed in 12 hours and 9 minutes.
